Vol 4 (April 2019): AME Medical Journal

Editorial Commentary 
Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality?
Daniele Lavacchi, Enrico Mini, Giandomenico Roviello
AME Medical Journal  
2019;
4:
24  
Medical Education Column 
The Science and Art of Medicine at McGill University
David H. Eidelman
AME Medical Journal  
2019;
4:
23  
Editorial Commentary 
Prostatectomy versus watchful waiting in patients with localized prostate cancer: the survival benefit can be spotted in the long run
Luca Afferi, Stefania Zamboni, Philipp Baumeister, Livio Mordasini, Agostino Mattei, Marco Moschini
AME Medical Journal  
2019;
4:
22  
Editorial Commentary 
Systemic and intestinal chronic inflammation, diet and cancer: an unbreakable bond
Cristiano Capurso
AME Medical Journal  
2019;
4:
21  
Medical Writing Corner 
Lost in translation
Jeremy Dean Chapnick
AME Medical Journal  
2019;
4:
20